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Objective: To study antiplasmodial and antioxidant activities of the isolation of alkaloids
from the active dichloromethane extract of Alseodaphne corneri.
Methods: Phytochemical studies of the crude extract led to the isolation of six alkaloids
using recycle high performance liquid chromatography and preparative thin layer chro-
matography. The antiplasmodial activity of the isolated compounds was evaluated using
the histidine-rich protein II assay. The isolated alkaloids were also tested for their anti-
oxidant activity using three different assays; DPPH, ferric reducing ability of plasma and
metal chelating assays.
Results: Malaria infection caused the formation of free radicals which subsequently led
to oxidative stress and apoptosis. The antioxidant properties of the alkaloids under
investigation revealed that in addition to the antiplasmodial activity, the alkaloids could
also prevent oxidative stress. (+)-laurotetanine and (+)-norstephasubine exhibited strong
antiplasmodial activities with IC50 values of 0.189 and 0.116 mM, respectively.
Conclusions: Interestingly, the two most potent compounds that exhibit antiplasmodial
activity also exhibit good antioxidant activities. The crude dichloromethane extract and
the isolated compounds exert substantial antiplasmodial and antioxidative activities which
in turn suppress oxidative stress and cause less damage to the host.1. Introduction
In modern world, vector-borne diseases still pose a great threat
to human health. Those from mosquitoes have killed millions of
human beings every year. Malaria is one of the serious vector-
borne diseases that people can catch after bitten by Anopheles
mosquitoes that are infected with parasites called Plasmodium.
Four different types of Plasmodium [Plasmodium falciparum
(P. falciparum), Plasmodium vivax, Plasmodium ovale, and
Plasmodium malariae] affect humans. According to the World
Health Organization [1], malaria is presently considered endemicand has caused approximately 198 million infections each year
especially in developing countries, with more than 584000
deaths in 2013. In Malaysia, 3850 malaria cases have been
reported with 14 deaths in the same year [2]. Plasmodium
knowlesi followed by P. falciparum are recognized as the main
cause of malaria in Malaysia [3,4]. Although the malaria rate has
decreased worldwide, however, the resistance to drug therapy
has increased. Chloroquine resistant was ﬁrst reported in
Peninsular Malaysia as early as 1963 [2]. Present drugs,
artemisinin and chloroquine, have become ineffective because
of the occurrence detected in 4 countries, Cambodia, Myanmar,
Thailand and Vietnam that are resistant to P. falciparum [1].
Plasmodium must acquire nutrients from the environment
(host) and convert it into other molecules or energy. This energy
will eventually be used for survival and the reproduction of the
parasites. The Plasmodium spp. requires amino acids for the
synthesis of their proteins from the host or through the digestion
of host hemoglobin. Growing substantial evidences have shown
that malaria arises as a result of free radical generation fromrticle under the CC BY-NC-ND license (http://
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oxidative stress has played an important role in the development of
systematic complication in hosts caused by malaria infection [5,6].
Wide varieties of compounds with synthetic antioxidative
properties have been used to reduce ROS formation and protect
DNA, lipid and protein damage against oxidative stress. The
preference of natural products is becoming signiﬁcant due to the
awareness of the public on the negative side effects caused by
synthetic drugs [7]. Therefore, natural products could provide a
template molecule which in turn leads to producing effective
antimalarial drugs. The combination of drugs that possess different
activities, artemisinin (antimalarial) and metalloporphyrins
(oxidizing reagents) acting synergistically on strains of
P. falciparum, has been reported [8]. It is known that this synergism
improves the survival rates, reduces the development of resistance
and might decrease the transmission of drug resistant parasites [9].
Thus, a single drug that can possess both antiplasmodial and
antioxidant activities simultaneously suppressing malaria, might be
a better choice compared to treatment with multiple drugs.
The genusAlseodaphne belongs to theLauraceae familywhich
is widely distributed fromYunan toWestMalaysia, Sri Lanka and
Burma. About 62 species have been identiﬁed till present, which
include trees or shrubs whereby 20 species are known to occur in
Malaysia. Alseodaphne is locally known as ‘Medang’. The plants
of this genus have been used as furniture, and to build boats and
houses. Alseodaphne corneri (A. corneri) is a small tree, with
about 6 m in height. Terminal bud is covered with many glabrous
scales. The twigs are stout and gray in color with prominent leaf
scars [10]. This genus is a rich source of isoquinoline alkaloids
particularly bisbenzylisoquinoline (BBIQ) alkaloids that exhibit
a wide range of pharmacological activities such as anti-
inﬂammatory, antibacterial and vasorelaxant [11,12]. Most of
BBIQ have been isolated from families Menispermaceae,
Berberidaceae, Monimiaceae and Ranunculaceae plants [13].
Our continuing activities on antiplasmodial screening of
Malaysian plants have revealed that dichloromethane (CH2Cl2)
bark extracts of A. corneri exhibited promising antiplasmodial
activity (IC50 = 2.78 mg/mL) [14,15]. Hence, in this study,
antiplasmodial and antioxidant activities of the isolation of
alkaloids from the active extract were explored.
2. Materials and methods
2.1. Instruments
Spectra were recorded using the following instruments; UV,
Shimadzu UV-250, UV-Visible spectrometer; IR, Perkin Elmer
1600; NMR, AVN BRUKER with CDCl3 as the solvent to
obtain the 400 MHz proton and 100 MHz carbon spectra. Mass
spectra were obtained using on Agilent technologies 6530
Accurate-Mass Q-TOF liquid chromatography/mass spectrom-
etry, with ZORBAX Eclipse XDB-C18 Rapid Resolution HT
4.6 mm i.d. × 50 mm × 1.8 mm column. All solvents, except
those used for bulk extraction were AR grade. Column chro-
matography separations were conducted by using Merck silica
gel 60 (230–400 mesh) and silica gel 60 F254 for thin layer
chromatography (TLC) monitoring. Recycle high performance
liquid chromatography was performed on LC-908W-C60.
Chromatographic analysis and separations were performed on
a JAIGEL GS320 (21.5 mm internal diameter, 500 mm L,
13 mm) size exclusion column using methanol (MeOH) as the
solvent. Glass and aluminum supported silica gel 60 F254 plateswere used for TLC. TLC spots were visualized under UV light
(254 nm and 365 nm) followed by spraying with Dragendroff's
reagent for alkaloid detection.
2.2. Plant material
The bark of A. corneri Kosterm was collected from Hutan
Simpan Kenderong, Gerik, Perak. The plant specimen was
identiﬁed by Eng and Nor and a voucher specimen (KL5641) of
this plant was deposited at the Herbarium of the Department of
Chemistry, University of Malaya, Kuala Lumpur, Malaysia.
2.3. Extraction and separation
Plant extraction was carried out by cold percolation. Dried
grounded bark ofA. corneri (2.0 kg)was ﬁrst defattedwith hexane
(17L) for three days at room temperature. Then, the hexane extract
was ﬁlters and dried on the rotary evaporator. The residues were
dried and then moistened with 25% ammonia solution and left for
2 h. The 40.0 g crude CH2Cl2 extract of alkaloids was subjected to
column chromatography using silica gel (0.040–0.063mm) as the
stationary phase usingmixtures of (CH2Cl2:MeOH) as the eluting
solvent (100:0, 99:1, 97:3, 96:4, and 90:1) to obtain eight fractions
(F1–F8). Alkaloid was puriﬁed from fraction F5 by a recycle high
performance liquid chromatography over JAIGEL size exclusion
column (21.5 mm internal diameter, 500 mm L, 13 mm) using
MeOH as solvent at a ﬂow rate of 4.0 mL/min. Three recycles in a
duration of 40 min afforded (−)-gyrolidine with retention times of
35 min. Further puriﬁcation of fraction F6 by a preparative TLC
using CH2Cl2: MeOH with 94:6; v/v, saturated with NH4OH;
Dragendroff's reagent gave alkaloids (+)-O-methyllimacusine,
(+)-2-norobaberine, (+)-laurotetanine, (+)-norstephasubine and
(+)-stephasubine.
2.4. Antiplasmodial assay
The crude CH2Cl2 extract and the isolated compounds were
evaluated for their in vitro antiplasmodial activity against
P. falciparum strain K1 which was resistant to chloroquine.
Chloroquine diphosphate was used as positive controls. The
screening was based on the ability to culture P. falciparum in
human erythrocytes in vitro. It was maintained in continuous
culture as described by Trager et al [16] with some modiﬁcation
[17]. The synchronization of the malaria culture to one stage was
by Lambros et al [18]. Antiplasmodial activity was evaluated
using histidine-rich protein II assay by enzyme linked immu-
nosorbent assay [19]. Micro titration techniques were used to
measure the activity of samples over a wide range of
concentrations. All tests were performed in duplicate. Crude
extract was dissolved in DMSO to produce a stock solution of
20 mg/mL. The stock solutions were subsequently diluted with
deionized water at 20 concentrations of two-fold dilutions into
two 96-well microtiter plates. A total of 10 mL of each con-
centration was transferred into another 96-well microtiter plates.
A total of 200 mL of parasitized red blood cell suspension (1%
parasitemia) were added to it. The mixtures were incubated for
24 h at 37 C and were subsequently cooled at −20 C to lyse the
red blood cells. The plates were allowed at room temperature,
and 20 mL of the blood suspension was dispensed into a new
microtiter plate containing 100 mL MALSTAT reagent, 20 mL
nitroblue tetrazolium and phenazine ethanosulphate mixture.
Absorbance was measured with an ELISA plate reader at
Table 1



















(−)-Gyrolidine 0.666 280.95 41.32 252.14
(+)-O-methyllimacusine 1.193 265.09 65.87 263.32
(+)-2-Norobaberine 0.743 254.95 51.50 351.80
(+)-Laurotetanine 0.189 131.72 89.22 153.25
(+)-Norstephasubine 0.116 130.42 74.25 104.58
(+)-Stephasubine 1.315 233.82 94.01 338.44
Chloroquine diphosphate 0.090 4.1.1 4.1.2 4.1.3
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determined and the mean of IC50 values of parasite sustainability
was calculated using analysis. The antiplasmodial activity of
each compound was expressed as an IC50 value deﬁned as the
concentration of the compounds causing 50% inhibition of
parasite growth relative to untreated control [20,21].
2.5. Antioxidant assay
2.5.1. DPPH assay
The DPPH scavenging activity of pure compounds were
tested based on the method previously published [22]. Brieﬂy,Figure 1. Structures of isolated compounds from A. corneri. 1: (−)-gyrolidine
(+)-norstephasubine; 6: (+)-stephasubine.40 mL of puriﬁed compounds at different concentrations were
mixed with 200 mL of 50 mM DPPH solution in MeOH. The
mixture was immediately shaken and incubated for 15 min in
the dark at room temperature. The decrease in absorbance was
measured at 517 nm with a microplate reader (Tecan Sunrise,
Austria). Ascorbic acid was used as a standard and the control
was MeOH. The percentage of inhibition activity of the
compounds was calculated (n = 3) and results were presented
in Table 1.
2.5.2. Metal chelating activity assay
The ferum ion chelating activity of the puriﬁed compounds
was determined according to the previously published [22] by
measuring the formation of the Fe2+-ferrozine complex in the
reaction mixture. Brieﬂy, 100 mL of puriﬁed compounds or
standards (6.25–100 mg/mL) were mixed with 120 mL distilled
water and 10 mL FeCl2 (2 mM) in a 96-well microplate and
the absorbance was read as blank. Then, 20 mL of ferrozine
(5 mM) was added to the mixture to initiate the reaction. The
reaction mixture was incubated at room temperature for 20 min
and the absorbance at 562 nm was measured. The results were
presented in Table 1 and butylated hydroxyanisole was used as
the standard reference.
2.5.3. FRAP
The reducing powerwas determinedusing themethod ofOyaizu
[23]. The tested compounds (0.5mL)dissolved in ethanol at different
doses (0, 50, 100, 150, 200 mg/mL) were mixed with phosphate
buffer (0.5 mL, 0.2 M, pH 6.6) and potassium ferricyanide
[K3Fe(CN)6] (0.5 mL, 1%). The mixture was then incubated at
50 C for 20 min. A total of 0.5 mL trichloroacetic acid (10%); 2: (+)-O-methyllimacusine; 3: (+)-2-norobaberine; 4: (+)-laurotetanine; 5:
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3000 rpm (1000 g). The upper layer of the solution (0.5 mL)
was mixed with distilled water (0.5 mL) and FeCl3 (0.1 mL,
0.1%) for 10 min, and then the absorbance was measured at
700 nm using a spectrophotometer. Ethylenediaminetetraacetic
acid was used as the standard reference (Table 1).
3. Results
This report communicated the isolation and characterization
of ﬁve BBIQ alkaloids (Figure 1), (−)-gyrolidine, (+)-O-meth-
yllimacusine, (+)-2-norobaberine, (+)-norstephasubine, (+)-ste-
phasubine, and one aporphine alkaloid (+)-laurotetanine from
the CH2Cl2 bark extract of A. corneri.
Structural elucidation was performed with the aid of spec-
troscopic methods notably; UV, IR, liquid chromatography/
Mass spectrometry, 1D and 2D NMR (COSY, HMBC, HMQC,
NOESY). The ESIMS showed a pseudomolecular ion peak m/z
at 623.30, 623.30, 609.29, 328.16, 576.23, and 591.13 corre-
sponding to alkaloids (−)-gyrolidine, (+)-O-methyllimacusine,
(+)-2-norobaberine, (+)-laurotetanine, (+)-norstephasubine and
(+)-stephasubine respectively. All the BBIQ alkaloids belonged
to type VI that had two diphenyl ether linkages between (C7–O–
C80) and (C11–O–C120). Generally, this could be deduced from
presence of seven aromatic proton signals in the form of ABX
and AA0BB0 systems, representing H-10, H-13, H-14 (ring C)
and H-100, H-110, H-130, H-140 (ring C0) respectively. As for the
aporphine alkaloid, (+)-laurotetanine, only three aromatic proton
signals appeared at dH 6.58, dH 6.78, dH 8.06 corresponding to
H-3, H-8 and H-11. The 13C NMR spectrum of BBIQ showed
between 34 and 36 carbon signals depending on the number of
substituents; whereas, aporphine only gave 20 carbon signals. In
addition, this was the ﬁrst occurrence of both antiplasmodial and
antioxidant activities of (−)-gyrolidine, (+)-O-methyllimacusine,
(+)-norstephasubine and (+)-stephasubine. Among the six
compounds evaluated for their antiplasmodial activity, (+)-nor-
stephasubine clearly showed the most potent in vitro anti-
plasmodial activity with an IC50 value of 0.116 mM that was
slightly better than the standard, chloroquine (IC50 = 0.090 mM).
In addition, (+)-laurotetanine also displayed a strong inhibition
capacity with an IC50 value of 0.189 mM, followed by;
(−)-gyrolidine, (+)-2-norobaberine, (+)-O-methyllimacusine,
and (+)-stephasubine (Table 1).
Furthermore, in order to evaluate the relationship between
suppression of oxidative stress and the cause of malaria, various
antioxidant assays (DPPH, FRAP, ferum metal chelating) were
performed. Interestingly, the two most potent compounds that
revealed antiplasmodial activity also exhibited good antioxidant
activities. Both (+)-laurotetanine and (+)-norstephasubine
showed high DPPH free radical scavenging activity and ferum
metal chelating activities which indicated that they were good
reductants and they also possessed the ability to chelate ferum
and prevent pro-oxidant activity (Table 1).
4. Discussion
The importance of antioxidant activity was to reverse or
minimize the oxidative damage to the hosts caused by Plasmo-
dium parasite from malaria infection. The iron bound in hemo-
globin is in Fe2+ form, and upon destruction of the hemoglobin,
oxidation of Fe2+ to Fe3+ occurs, followed by the release of a freeelectron that eventually generate ROS. The generation of ROS
such as hydrogen peroxide, hydroxyl radical and superoxide
anion radical will induce oxidative damage [24,25]. Malaria
infection induces the generation of the hydroxyl radical in the
liver, which will most probably lead to the induction of
oxidative stress and apoptosis [8].
It is worthy to note that, Plasmodium parasites from malaria
infection invade the host hemoglobin to make their own protein.
Upon destruction, free heme (ferum atom) will be released and
converted to hemozoin which is important for the survival of
Plasmodium parasites. Therefore by having strong ferum che-
lation, as shown by (+)-laurotetanine and (+)-norstephasubine,
the killing of Plasmodium by binding to toxic free heme could
prevent the formation of hemozoin [8,26].
The high antioxidant activities of those alkaloids may be due
to the hydroxyl group that could donate electron to the free
radicals which showed high radical scavenging activities that
could suppress the oxidative stress on the host. The hydroxyl
group that could donate electron to the notorious free radical
could be the reason why it possesses potent radical scavenging
activities (DPPH) [27,28].
Malaria infection causes the formation of free radicals which
subsequently leads to oxidative stress and apoptosis. The crude
CH2Cl2 extract and the isolated compounds from the bark of
A. corneri exert substantial antiplasmodial and antioxidative
effects through the DPPH free radical scavenging FRAP and
metal chelating activities which could suppress oxidative stress
that cause less damage to the host. The two most potent anti-
plasmodial alkaloids, (+)-laurotetanine and (+)-norstephasubine,
also exhibited potent FRAP and metal chelating antioxidant
activities. Therefore, these alkaloids may be good candidates for
drug development of potential antimalarial properties possessing
antioxidant capability.
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